Workflow
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
EWEdwards(EW) Zacks Investment Research·2024-04-25 23:01

Edwards Lifesciences (EW) reported 1.6billioninrevenueforthequarterendedMarch2024,representingayearoveryearincreaseof9.51.6 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 9.5%. EPS of 0.66 for the same period compares to 0.62ayearago.Thereportedrevenuerepresentsasurpriseof+1.430.62 a year ago.The reported revenue represents a surprise of +1.43% over the Zacks Consensus Estimate of 1.58 billion. With the consensus EPS estimate being $0.64, the EPS surprise was +3.13%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determ ...